Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infections

Vaccine

Volumn 32, Issue 14, 2014, Pages 1543-1552

  Brotman, Rebecca M ^a   Ravel, Jacques ^a   Bavoil, Patrik M ^b   Gravitt, Patti E ^c   Ghanem, Khalil G ^d,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JHUBMC   (United States)

Author keywords

Mucosal immunology; Review; Sex hormones; Sexually transmitted infections; Vaccines; Vaginal microbiota

Indexed keywords

SEX HORMONE; VACCINE;

ADAPTIVE IMMUNITY; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL COLONIZATION; CELL COMPARTMENTALIZATION; CELLULAR IMMUNITY; FEMALE GENITAL SYSTEM; GENITAL SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MALE GENITAL SYSTEM; MICROBIAL COMMUNITY; MICROBIOME; MICROFLORA; MUCOSAL IMMUNITY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VAGINA FLORA;

MUCOSAL IMMUNOLOGY; REVIEW; SEX HORMONES; SEXUALLY TRANSMITTED INFECTIONS; VACCINES; VAGINAL MICROBIOTA;

ADAPTIVE IMMUNITY; FEMALE; GENITALIA, MALE; GONADAL STEROID HORMONES; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; MALE; MICROBIOTA; SEXUALLY TRANSMITTED DISEASES; VACCINES; VAGINA;

EID: 84896697511     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.10.010     Document Type: Article

References (123)

1. McDermott M.R., Clark D.A., Bienenstock J. Evidence for a common mucosal immunologic system II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol 1980, 124:2536-2539.
2. Terho P., Meurman O. Chlamydial serum IgG, IgA and local IgA antibodies in patients with genital-tract infections measured by solid-phase radioimmunoassay. J Med Microbiol 1981, 14:77-87.
3. Kelly K.A., Rank R.G. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 1997, 65:5198-5208.
4. Cain T.K., Rank R.G. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995, 63:1784-1789.
5. Russell M.W., Mestecky J. Humoral immune responses to microbial infections in the genital tract. Microbes Infect 2002, 4:667-677.
6. Pudney J., Quayle A.J., Anderson D.J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005, 73:1253-1263.
7. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
8. Wira C.R., Fahey J.V., Ghosh M., Patel M.V., Hickey D.K., Ochiel D.O. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol 2010, 63:544-565.
9. Wira C.R., Ghosh M., Smith J.M., Shen L., Connor R.I., Sundstrom P., et al. Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol 2011, 4:335-342.
10. Selsted M.E., Ouellette A.J. Defensins in granules of phagocytic and non-phagocytic cells. Trends Cell Biol 1995, 5:114-119.
11. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003, 3:710-720.
12. Iijima N., Thompson J.M., Iwasaki A. Dendritic cells and macrophages in the genitourinary tract. Mucosal Immunol 2008, 1:451-459.
13. Sigmundsdottir H., Butcher E.C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 2008, 9:981-987.
14. Luci C., Hervouet C., Rousseau D., Holmgren J., Czerkinsky C., Anjuère F. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol 2006, 176:2749-2757.
15. Mselle T.F., Meadows S.K., Eriksson M., Smith J.M., Shen L., Wira C.R., et al. Unique characteristics of NK cells throughout the human female reproductive tract. Clin Immunol 2007, 124:69-76.
16. Sonnenberg G.F., Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012, 37:601-610.
17. Veldhoen M., Withers D.R. Immunology. Innate lymphoid cell relations. Science 2010, 330:594-595.
18. Mestecky J., Raska M., Novak J., Alexander R.C., Moldoveanu Z. Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design. J Reprod Immunol 2010, 85:81-85.
19. Renegar K.B., Jackson G.D., Mestecky J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol 1998, 160:1219-1223.
20. Russell M.W., Reinholdt J., Kilian M. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation. Eur J Immunol 1989, 19:2243-2249.
21. Corthesy B. Roundtrip ticket for secretory IgA: role in mucosal homeostasis. J Immunol 2007, 178:27-32.
22. Naz R.K., Menge A.C. Antisperm antibodies: origin, regulation, and sperm reactivity in human infertility. Fertil Steril 1994, 61:1001-1013.
23. Kutteh W.H., Moldoveanu Z., Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998, 14(Suppl. 1):S51-S55.
24. Kamat B.R., Isaacson P.G. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am J Pathol 1987, 127:66-73.
25. Feinen B., Jerse A.E., Gaffen S.L., Russell M.W. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol 2010, 3:312-321.
26. Chege D., Chai Y., Huibner S., Kain T., Wachihi C., Kimani M., et al. Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya. PLOS ONE 2012, 7:e43670.
27. Nakanishi Y., Lu B., Gerard C., Iwasaki A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009, 462:510-513.
28. Cuburu N., Graham B.S., Buck C.B., Kines R.C., Pang Y.Y., Day P.M., et al. Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J Clin Invest 2012, 122:4606-4620.
29. Shin H., Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012, 491:463-467.
30. Russo C.L., Spurr-Michaud S., Tisdale A., Pudney J., Anderson D., Gipson I.K. Mucin gene expression in human male urogenital tract epithelia. Hum Reprod 2006, 21:2783-2793.
31. Lievin-Le Moal V., Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 2006, 19:315-337.
32. Pudney J., Anderson D.J. Immunobiology of the human penile urethra. Am J Pathol 1995, 147:155-165.
33. Pudney J., Anderson D. Innate and acquired immunity in the human penile urethra. J Reprod Immunol 2011, 88:219-227.
34. Bomar L., Maltz M., Colston S., Graf J. Directed culturing of microorganisms using metatranscriptomics. mBio 2011, 2. e00012-11.
35. Amann R.I., Ludwig W., Schleifer K.H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 1995, 59:69-143.
36. Ferreira R.B.R., Antunes L.C.M., Finlay B.B. Should the human microbiome be considered when developing vaccines?. PLoS Pathog 2010, 6:e1001190.
37. Gill N., Finlay B.B. The gut microbiota: challenging immunology. Nat Rev Immunol 2011, 11:7-636.
38. Eloe-Fadrosh E.A., McArthur M.A., Seekatz A.M., Drabek E.F., Rasko D.A., Sztein M.B., et al. Impact of oral typhoid vaccination on the human gut microbiota and correlations with S. Typhi-specific immunological responses. PLOS ONE 2013, 8:e62026.
39. Bjorksten B. Diverse microbial exposure - consequences for vaccine development. Vaccine 2012, 30:40-4336.
40. Isolauri E., Joensuu J., Suomalainen H., Luomala M., Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995, 13:310-2310.
41. Azevedo M.S.P., Zhang W., Wen K., Gonzalez A.M., Saif L.J., Yousef A.E., et al. Lactobacillus acidophilus and Lactobacillus reuteri modulate cytokine responses in gnotobiotic pigs infected with human rotavirus. Benef Microbes 2012, 3:33-42.
42. Fang H., Elina T., Heikki A., Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol Med Microbiol 2000, 29:47-52.
43. Vrese M., Rautenberg P., Laue C., Koopmans M., Herremans T., Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 2004, 44:13-406.
44. Focareta A., Paton J.C., Morona R., Cook J., Paton A.W. A recombinant probiotic for treatment and prevention of cholera. Gastroenterology 2006, 130:95-1688.
45. Paineau D., Carcano D., Leyer G., Darquy S., Alyanakian M.-A., Simoneau G., et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 2008, 53:13-107.
46. Matsuda F., Chowdhury M.I., Saha A., Asahara T., Nomoto K., Tarique A.A., et al. Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 2011, 29:8-1855.
47. Kukkonen K., Nieminen T., Poussa T., Savilahti E., Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy - a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol 2006, 17:214-216.
48. West C.E., Gothefors L., Granström M., Käyhty H., Hammarström M.-L.K.C., Hernell O. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol 2007, 19:53-60.
49. Soh S.E., Ong D.Q.R., Gerez I., Zhang X., Chollate P., Shek L.P-C., et al. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010, 28:9-2577.
50. Hillier S.L. Normal vaginal flora. Sexually transmitted diseases 2008, 289-307. McGraw-Hill, New York. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J. Wasserheit, L. Corey, M. Cohen (Eds.).
51. Kirjavainen P.V., Pautler S., Baroja M.L., Anukam K., Crowley K., Carter K., et al. Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vaccine Immunol 2009, 16:29-36.
52. Ravel J., Gajer P., Abdo Z., Schneider G.M., Koenig S.S., McCulle S.L., et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011, 108(Suppl. 1):7-4680.
53. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005, 353:911-1899.
54. Gajer P., Brotman R.M., Bai G., Sakamoto J., Schutte U.M., Zhong X., et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 2012, 4:132ra52.
55. O'Hanlon D.E., Moench T.R., Cone R.A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis 2011, 11:200.
56. Peipert J.F., Lapane K.L., Allsworth J.E., Redding C.A., Blume J.D., Stein M.D. Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association. Sex Transm Dis 2008, 35:7-363.
57. Brotman R.M., Klebanoff M.A., Nansel T.R., Yu K.F., Andrews W.W., Zhang J., et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 2010, 202:15-1907.
58. Cherpes T.L., Meyn L.A., Krohn M.A., Lurie J.G., Hillier S.L. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003, 37:25-319.
59. Martin H.L., Richardson B.A., Nyange P.M., Lavreys L., Hillier S.L., Chohan B., et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999, 180:8-1863.
60. King C.C., Jamieson D.J., Wiener J., Cu-Uvin S., Klein R.S., Rompalo A.M., et al. Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol 2011, 2011:319460.
61. Myer L., Denny L., Telerant R., Souza M., Wright T.C., Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 2005, 192:80-1372.
62. Cu-Uvin S., Hogan J.W., Caliendo A.M., Harwell J., Mayer K.H., Carpenter C.C., et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001, 33:6-894.
63. Sha B.E., Zariffard M.R., Wang Q.J., Chen H.Y., Bremer J., Cohen M.H., et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005, 191:25-32.
64. Coleman J.S., Hitti J., Bukusi E.A., Mwachari C., Muliro A., Nguti R., et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007, 21:9-755.
65. Mitchell C., Balkus J.E., Fredricks D., Liu C., McKernan-Mullin J., Frenkel L.M., et al. Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV type 1 RNA and DNA genital shedding in U.S. and Kenyan women. AIDS Res Hum Retroviruses 2013, 29:9-13.
66. Cherpes T.L., Melan M.A., Kant J.A., Cosentino L.A., Meyn L.A., Hillier S.L. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005, 40:8-1422.
67. Cohen C.R., Lingappa J.R., Baeten J.M., Ngayo M.O., Spiegel C.A., Hong T., et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 2012, 9:e1001251.
68. Sobel J.D. Bacterial vaginosis. Annu Rev Med 2000, 51:56-349.
69. Schwebke J.R., Hillier S.L., Sobel J.D., McGregor J.A., Sweet R.L. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996, 88:6-573.
70. Marrazzo J.M. A persistent(ly) enigmatic ecological mystery: bacterial vaginosis. J Infect Dis 2006, 193:7-1475.
71. Fethers K.A., Fairley C.K., Hocking J.S., Gurrin L.C., Bradshaw C.S. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis 2008, 47:35-1426.
72. Brotman R.M., Klebanoff M.A., Nansel T.R., Andrews W.W., Schwebke J.R., Zhang J., et al. A longitudinal study of vaginal douching and bacterial vaginosis - a marginal structural modeling analysis. Am J Epidemiol 2008, 168:96-188.
73. Schwebke J.R. Bacterial vaginosis: are we coming full circle. J Infect Dis 2009, 200:5-1633.
74. Koumans E.H., Sternberg M., Bruce C., McQuillan G., Kendrick J., Sutton M., et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007, 34:9-864.
75. Eschenbach D.A., Thwin S.S., Patton D.L., Hooton T.M., Stapleton A.E., Agnew K., et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 2000, 30:7-901.
76. Pavlova S.I., Tao L. Induction of vaginal Lactobacillus phages by the cigarette smoke chemical benzo[a]pyrene diol epoxide. Mutat Res 2000, 466:57-62.
77. Marrazzo J.M., Koutsky L.A., Eschenbach D.A., Agnew K., Stine K., Hillier S.L. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 2002, 185:13-1307.
78. Srinivasan S., Liu C., Mitchell C.M., Fiedler T.L., Thomas K.K., Agnew K.J., et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE 2010, 5:e10197.
79. Zariffard M.R., Novak R.M., Lurain N., Sha B.E., Graham P., Spear G.T. Induction of tumor necrosis factor-alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 2005, 191:21-1913.
80. St John E.P., Martinson J., Simoes J.A., Landay A.L., Spear G.T. Dendritic cell activation and maturation induced by mucosal fluid from women with bacterial vaginosis. Clin Immunol 2007, 125:95-102.
81. Mirmonsef P., Gilbert D., Zariffard M.R., Hamaker B.R., Kaur A., Landay A.L., et al. The effects of commensal bacteria on innate immune responses in the female genital tract. Am J Reprod Immunol 2011, 65:5-190.
82. Lewis W.G., Robinson L.S., Perry J., Bick J.L., Peipert J.F., Allsworth J.E., et al. Hydrolysis of secreted sialoglycoprotein immunoglobulin A (IgA) in ex vivo and biochemical models of bacterial vaginosis. J Biol Chem 2012, 287:89-2079.
83. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
84. Nelson D.E., Dong Q., Van der Pol B., Toh E., Fan B., Katz B.P., et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLOS ONE 2012, 7:e36298.
85. Dong Q., Nelson D.E., Toh E., Diao L., Gao X., Fortenberry J.D., et al. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLOS ONE 2011, 6:e19709.
86. Price L.B., Liu C.M., Johnson K.E., Aziz M., Lau M.K., Bowers J., et al. The effects of circumcision on the penis microbiome. PLoS ONE 2010, 5:e8422.
87. Tobian A.A.R., Gray R.H. The medical benefits of male circumcision. JAMA 2011, 306:80-1479.
88. Mehta S.D., Gaydos C., MacLean I., Odoyo-June E., Moses S., Agunda L., et al. The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya. Sex Transm Dis 2012, 39:80-276.
89. Mehta S.D., Moses S., Parker C.B., Agot K., MacLean I., Bailey R.C. Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS 2012, 26:9-1141.
90. Wira C.R., Fahey J.V., Sentman C.L., Pioli P.A., Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005, 206:35-306.
91. Wira C.R., Patel M.V., Ghosh M., Mukura L., Fahey J.V. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol 2011, 65:196-211.
92. Wira C.R., Fahey J.V. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008, 22:17-1909.
93. Kyongo J.K., Jespers V., Goovaerts O., Michiels J., Menten J., Fichorova R.N., et al. Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women. PLOS ONE 2012, 7:e43951.
94. Kumar R., Vicari M., Gori I., Achtari C., Fiche M., Surbeck I., et al. Compartmentalized secretory leukocyte protease inhibitor expression and hormone responses along the reproductive tract of postmenopausal women. J Reprod Immunol 2011, 92:88-96.
95. Fahey J.V., Wira C.R. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002, 185:13-1606.
96. Morrison C.S., Turner A.N., Jones L.B. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009, 23:84-263.
97. Blish C.A., Baeten J.M. Hormonal contraception and HIV-1 transmission. Am J Reprod Immunol 2011, 65:7-302.
98. Klinger G., Eick S., Klinger G., Pfister W., Graser T., Moore C., et al. Influence of hormonal contraceptives on microbial flora of gingival sulcus. Contraception 1998, 57:4-381.
99. Riggs M., Klebanoff M., Nansel T., Zhang J., Schwebke J., Andrews W. Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis 2007, 34:9-954.
100. Rifkin S.B., Smith M.R., Brotman R.M., Gindi R.M., Erbelding E.J. Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD. Contraception 2009, 80:7-63.
101. McClelland R.S., Richardson B.A., Graham S.M., Masese L.N., Gitau R., Lavreys L., et al. A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sex Transm Dis 2008, 35:23-617.
102. Bradshaw C.S., Morton A.N., Hocking J., Garland S.M., Morris M.B., Moss L.M., et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006, 193:86-1478.
103. Smart S., Singal A., Mindel A. Social and sexual risk factors for bacterial vaginosis. Sex Transm Infect 2004, 80:58-62.
104. Cruickshank R. The conversion of the glycogen of the vagina into lactic acid. J Pathol Bacteriol 1934, 39:213-219.
105. Preti G., Huggins G. The human vagina 1978, Elsevier North-Holland Biomedical Press, Amsterdam/New York.
106. Romero R. The vaginal microbiome during pregnancy and before preterm labor and delivery. 59th annual meeting of the society for gynecological investigations 2012.
107. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002, 347:51-1645.
108. Naz R.K. Female genital tract immunity: distinct immunological challenges for vaccine development. J Reprod Immunol 2012, 93:1-8.
109. Kozlowski P.A., Cu-Uvin S., Neutra M.R., Flanigan T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 1997, 65:94-1387.
110. Russell M.W., Mestecky J. Tolerance and protection against infection in the genital tract. Immunol Invest 2010, 39:25-500.
111. Kaushic C., Ashkar A.A., Reid L.A., Rosenthal K.L. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 2003, 77:65-4558.
112. Gillgrass A.E., Ashkar A.A., Rosenthal K.L., Kaushic C. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol 2003, 77:51-9845.
113. Johansson E.L., Rask C., Fredriksson M., Eriksson K., Czerkinsky C., Holmgren J. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 1998, 66:20-514.
114. Nardelli-Haefliger D., Wirthner D., Schiller J.T., Lowy D.R., Hildesheim A., Ponci F., et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003, 95:37-1128.
115. Schiller J.T., Lowy D.R. Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol 2012, 10:92-681.
116. Stanberry L.R., Spruance S.L., Cunningham A.L., Bernstein D.I., Mindel A., Sacks S., et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002, 347:61-1652.
117. Belshe R.B., Leone P.A., Bernstein D.I., Wald A., Levin M.J., Stapleton J.T., et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012, 366:34-43.
118. Boslego J.W., Tramont E.C., Chung R.C., McChesney D.G., Ciak J., Sadoff J.C., et al. Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 1991, 9:62-154.
119. Greenberg L., Diena B.B., Ashton F.A., Wallace R., Kenny C.P., Znamirowski R., et al. Gonococcal vaccine studies in Inuvik. Can J Public Health 1974, 65:29-33.
120. Huston W.M., Harvie M., Mittal A., Timms P., Beagley K.W. Vaccination to protect against infection of the female reproductive tract. Expert Rev Clin Immunol 2012, 8:81-94.
121. Fukuyama Y., Tokuhara D., Kataoka K., Gilbert R.S., McGhee J.R., Yuki Y., et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012, 11:79-367.
122. Gebril A., Alsaadi M., Acevedo R., Mullen A.B., Ferro V.A. Optimizing efficacy of mucosal vaccines. Expert Rev Vaccines 2012, 11:55-1139.
123. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012, 12:592-605.